health pharma news today obesity drugs glp-1 today India Tightens Oversight on Weight Loss Are rapid weight-loss injections becoming a growing concern in India? India's healthcare regulators are increasing monitoring of GLP-1 drugs like Semaglutide and Ozempic Novo Nordisk launches Wegovy weight-loss

Activation of the canonical WNT pathway by lithium: a potential therapeutic strategy Lithium and GSK-3 A recent study has observed that mutant murine models of OCD presented increased GSK-3 activity and thus its inhibition could be a treatment of perseverative behaviors 70

Tighe MP, Cummings JR, Afzal NA

Since GSH is the final product of the homocysteine metabolism in the transsulfuration pathway by transferring sulfur from homocysteine to cysteine, a deficiency in transsulfuration pathway leads to excessive homocysteine production (hyperhomocysteinemia) and reduced GSH synthesis (159, 160)

Because this version delivers a higher dose per vial, practitioners often choose it for patients seeking a more pronounced brightening effect or continuing an established treatment plan